Literature DB >> 7002083

Bullous pemphigoid as a manifestation of chronic lymphocytic leukemia.

L T Goodnough, W A Muir.   

Abstract

We describe a patient with chronic lymphocytic leukemia (CLL) and bullous pemphigoid. Initial treatment with high-dose prednisone (60 mg/day for 14 days) failed to prevent occurrence of new skin lesions. After the addition of chlorambucil, 6 mg/day, and tapering the prednisone dosage, no new skin lesions appeared, and the bullous lesions rapidly resolved. We were unable to isolate an antibody produced by leukemic lymphocytes that is directed against subepithelial basement membrane. Nevertheless, we believe that bullous pemphigoid can be a peripheral manifestation of an underlying disease such as CLL. Confirmation of this would be aided by the isolation of antibody produced by leukemic cells that is directed against subepithelial basement membrane.

Entities:  

Mesh:

Year:  1980        PMID: 7002083

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Systemic sclerosis and chronic lymphocytic leukaemia.

Authors:  Y Sidi; R Fadilah; J Pinkhas; M Prokocimer
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Autoimmunity in chronic lymphocytic leukaemia.

Authors:  T J Hamblin; D G Oscier; B J Young
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

3.  Oral lesions and lymphoproliferative disorders.

Authors:  P Castellarin; G Pozzato; G Tirelli; R Di Lenarda; M Biasotto
Journal:  J Oncol       Date:  2010-09-01       Impact factor: 4.375

Review 4.  Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets.

Authors:  Quincy A Quick
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.